Legend Biotech Corporation (FRA:9LB)
Germany · Delayed Price · Currency is EUR 14.70
-0.40 (-2.65%)
At close: Mar 27, 2026
Legend Biotech Market Cap
Legend Biotech has a market cap or net worth of €2.7 billion as of March 27, 2026. Its market cap has decreased by -58.07% in one year.
Market Cap
2.70B
Enterprise Value
2.23B
Revenue
876.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
€14.70
Market Cap Chart
Since June 5, 2020, Legend Biotech's market cap has decreased from 4.23B to 2.70B, a decrease of -36.23%. That is a compound annual growth rate of -7.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 2.70B | -21.14% |
| Dec 31, 2025 | 3.42B | -40.69% |
| Dec 31, 2024 | 5.77B | -41.73% |
| Dec 29, 2023 | 9.90B | 26.55% |
| Dec 30, 2022 | 7.82B | 23.93% |
| Dec 31, 2021 | 6.31B | 106.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest Aktiengesellschaft | 1.44B |
| Darwin AG | 92.40M |
| 2invest AG | 62.87M |
| Biomark Diagnostics | 37.83M |
| co.don AG | 360.77K |
| bioXXmed AG | 323.52K |
| Paion AG | 232.56K |
| MagForce AG | 137.58K |